Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection
Liver International · 2023
DOI: 10.1111/liv.15719 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Filippo Pelizzaro und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Transplantation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was funded by the University of Padua and by DOR 2022 granted to Filippo Pelizzaro.
Abstract (Originalsprache)
Background and Aims Hepatocellular carcinoma (HCC) recurrence is common in patients treated with liver resection (LR). In this study, we aimed to evaluate the incidence and preoperative predictors of non‐transplantable recurrence in patients with single HCC ≤5 cm treated with frontline LR. Methods From the Italian Liver Cancer (ITA.LI.CA) database, 512 patients receiving frontline LR for single HCC ≤5 cm were retrieved. Incidence and predictors of recurrence beyond Milan criteria (MC) and up‐to‐seven criteria were compared between patients with HCC
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
- Gastroenterology Unit, Azienda Ospedale-Università di Padova, Padova, Italy.
- Unit of Semeiotics, Liver and Alcohol-related diseases, Department of Medical and Surgical Sciences, Università di Bologna, Bologna, Italy.
- Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Medical Statistics Unit, Mental, Physical Health and Preventive Medicine, University of Campania 'Luigi Vanvitelli', Napoli, Italy.
- Hepatobiliary Surgery and Liver Transplantation Unit, Azienda Ospedale-Università di Padova, Padova, Italy.
ORCID-Profile: Filippo Pelizzaro, Franco Trevisani, Alessandro Vitale, Fabio Piscaglia, Gabriele Missale, Angelo Sangiovanni, Maurizia R Brunetto, Giovanni Raimondo, Gianpaolo Vidili, Maria Guarino, Antonio Gasbarrini, Claudia Campani, Gianluca Svegliati-Baroni, Edoardo G Giannini, Gerardo Nardone, Fabio Farinati
Förderung
- This work was funded by the University of Padua and by DOR 2022 granted to Filippo Pelizzaro
Zitieren
APA
Pelizzaro, F., Trevisani, F., Simeon, V., Vitale, A., Cillo, U., Piscaglia, F., Missale, G., Sangiovanni, A., Foschi, F. G., Cabibbo, G., Caturelli, E., Di Marco, M., Azzaroli, F., Brunetto, M. R., Raimondo, G., Vidili, G., Guarino, M., Gasbarrini, A., Campani, C., …, & Italian Liver Cancer (ITA.LI.CA) group (2023). Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection. Liver International. https://doi.org/10.1111/liv.15719
Vancouver
Pelizzaro F, Trevisani F, Simeon V, Vitale A, Cillo U, Piscaglia F, et al. Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection. Liver International. 2023. doi:10.1111/liv.15719
BibTeX
@article{Pelizzaro2023,
author = {Pelizzaro, Filippo and Trevisani, Franco and Simeon, Vittorio and Vitale, Alessandro and Cillo, Umberto and Piscaglia, Fabio and Missale, Gabriele and Sangiovanni, Angelo and Foschi, Francesco G and Cabibbo, Giuseppe and Caturelli, Eugenio and Di Marco, Maria and Azzaroli, Francesco and Brunetto, Maurizia R and Raimondo, Giovanni and Vidili, Gianpaolo and Guarino, Maria and Gasbarrini, Antonio and Campani, Claudia and Svegliati-Baroni, Gianluca and Giannini, Edoardo G and Mega, Andrea and Masotto, Alberto and Rapaccini, Gian Ludovico and Magalotti, Donatella and Sacco, Rodolfo and Nardone, Gerardo and Farinati, Fabio and Italian Liver Cancer (ITA.LI.CA) group, Italian Liver Cancer (ITA.LI.CA) group},
title = {Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection},
journal = {Liver International},
year = {2023},
doi = {10.1111/liv.15719}
}
EUVIMED